🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in Canada / NCT05825937
Recruiting Observational

Non-Invasive Blood Pressure Monitoring

NCT05825937 · tracked via the Priya Life Science Canada tracker
Phase
Observational
Started
2021-06-01
Last updated
2025-05-11

Condition(s) studied

Blood Pressure

Investigational drug(s) / intervention(s)

ClearSight System

ClearSight System: Patients having either elective cardiac surgery or elective neurointerventional surgery will have blood pressure monitored by the ClearSight device, along with the standard of care radial arterial line, throughout their surgery. The arterial line will be placed on the radial artery contralateral to the upper arm blood pressure cuff. The ClearSight device will then be placed on the third finger of the hand ipsilateral to the radial arterial line.

Study summary

The purpose of this study is to evaluate an alternative way of continuously measuring blood pressure in patients coming for complex surgery. The investigators will directly compare the speed of set up and accuracy of the new ClearSight monitor to those taken by the arterial line monitor, which is the current gold standard for recording blood pressure measurements.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * written informed consent * undergoing elective cardiac surgery OR elective neurointerventional surgery (with standard arterial radial line for continuous blood pressure monitoring) Exclusion Criteria: * undergoing emergent cardiac surgery OR emergent neurointerventional surgery

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Royal University Hospital Saskatoon Saskatchewan Recruiting

More University of Saskatchewan trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05825937 on ClinicalTrials.gov ↗ ← All trials in Canada